Merck Gets Positive CHMP Opinion for Keytruda in Mesothelioma
The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...
Why Are Younger People Getting Cancer?
Cancer is on the rise in America - especially among younger adults. Learn about what lifestyle choices may help to avoid early-onset cancer.
Vaccinex, Inc.: Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Actively Exploring Partnership for Alzheimer's DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage bio ...
Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now?
We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...
Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of Semaphorin 4D ...
Guess which small cap ASX share could rise 100%+
Bell Potter is tipping this speculative small cap ASX share to more than double in value over the next 12 months. Here's why ...